Related references
Note: Only part of the references are listed.Growth Differentiation Factor-15 as a Biomarker of Obese Pre-diabetes and Type 2 Diabetes Mellitus in Indian Subjects: A Case-control Study
Dipayan Roy et al.
CURRENT DIABETES REVIEWS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
Yena Cho et al.
FRONTIERS IN ONCOLOGY (2020)
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
Parham Jabbarzadeh Kaboli et al.
PHARMACOLOGICAL RESEARCH (2020)
Optimising total RNA quality and quantity by phenol-chloroform extraction method from human visceral adipose tissue: A standardisation study
Dipayan Roy et al.
METHODSX (2020)
Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
Apurv Kulkarni et al.
JCO GLOBAL ONCOLOGY (2020)
Molecular classification of breast cancer: A retrospective cohort study
Fatma Khinaifis Al-thoubaity
ANNALS OF MEDICINE AND SURGERY (2020)
Growth differentiation factor 15: A novel biomarker with high clinical potential
Stephanie Desmedt et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
Uku Raudvere et al.
NUCLEIC ACIDS RESEARCH (2019)
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Kha-Liang Lee et al.
CANCERS (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
Sangita Sridharan et al.
FRONTIERS IN ONCOLOGY (2019)
Growth differentiation factor 15 and its role in carcinogenesis: an update
Anupama Modi et al.
GROWTH FACTORS (2019)
OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer
Jia-Ming Zhang et al.
BREAST CANCER (2018)
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
Peng Liu et al.
FRONTIERS IN PHARMACOLOGY (2018)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
Fei Ma et al.
MEDICINE (2017)
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Youxiang Hou et al.
CELL DEATH & DISEASE (2017)
Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling
Bridgette F. Peake et al.
ONCOTARGET (2017)
An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells
Asako Sasahara et al.
ONCOTARGET (2017)
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
Jae Moon Gwak et al.
ONCOTARGET (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
MIC1/GDF15 as a Bone Metastatic Disease Biomarker
Jindra Windrichova et al.
ANTICANCER RESEARCH (2017)
POU5F1/Oct-4 expression in breast cancer tissue is significantly associated with non-sentinel lymph node metastasis
Shouliang Cai et al.
BMC CANCER (2016)
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway
Guanzhen Yu et al.
ONCOTARGET (2015)
SOX2 promotes tumorigenicity and inhibits the differentiation of I-type neuroblastoma cells
Shaobo Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic
Youhong Liu et al.
MOLECULAR CARCINOGENESIS (2014)
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
Dan Wang et al.
ONCOTARGET (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
Clinicopathologic Implications of EpCAM and Sox2 Expression in Breast Cancer
Nehad M.R. Abd El-Maqsoud et al.
Clinical Breast Cancer (2013)
Clinical Implications of Stem Cell Gene Oct-4 Expression in Breast Cancer
Cai-gang Liu et al.
ANNALS OF SURGERY (2011)
Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells
Jayashree P. Joshi et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Jimmy M. -M. Kwok et al.
MOLECULAR CANCER RESEARCH (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells
Zhongqiu Xie et al.
NUCLEIC ACIDS RESEARCH (2010)
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
Susumu Saigusa et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
